Details for Patent: 5,130,120

Summary for Patent: 5,130,120

Title:	Paramagnetic DTPA and EDTA alkoxyalkylamide complexes as MRI agents
Abstract:	Novel magnetic resonance imaging agents and methods which utilize complexes of paramagnetic ions with alkoxyalkylamide derivatives of diethylenetriaminepentaacetic acid ("DTPA") or ethylenediaminetetraacetic acid ("EDTA"). These novel imaging agents are characterized by excellent NMR image-contrasting properties and by high solubilities in physiological solutions. The complexes are represented by the following formula: ##STR1## wherein A is --CH.sub.2 CH.sub.2 -- or ##STR2## and M.sup.+z is a paramagnetic ion of an element with an atomic number of 21-29, 42-44 or 58-70, and a valence, Z, of 2 or 3; the R groups may be the same or different and are selected from the group consisting of -O.sup..crclbar. and lower alkoxyalkylamino groups having from 2 to about 6 carbon atoms, wherein the number of R groups -O.sup..crclbar. equals Z and the remaining R groups are lower alkoxyalkylamino, equal to 4-Z when A is --CH.sub.2 CH.sub.2 --, or 5-Z when A ##STR3##
Inventor(s):	Weber; Robert W. (Downingtown, PA)
Assignee:	Mallinckrodt Medical, Inc. (St. Louis, MO)
Application Number:	07/221,425
Patent Claim Types: see list of patent claims	Compound; Composition; Dosage form; Use;

Drugs Protected by US Patent 5,130,120

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

International Family Members for US Patent 5,130,120

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	142614
Australia	3988589
Australia	650615
Brazil	1101072
Canada	1339821
Germany	122007000068
Germany	68927173